1336975-57-5 Usage
Uses
Used in Pharmaceutical Industry:
2'-b-C-Methyl-2-aMino-N6,N6-diMethyladenosine is used as a potential therapeutic agent for the treatment of certain diseases. Its role in regulating cellular processes such as protein synthesis and gene expression suggests that it may have potential applications in the development of drugs targeting these pathways.
Used in Biotechnology Industry:
2'-b-C-Methyl-2-aMino-N6,N6-diMethyladenosine is used in research and development of biotechnological applications. Its presence in transfer RNA and its role in regulating the translation of genetic information into proteins make it a valuable target for studying the mechanisms of gene expression and protein synthesis. This knowledge can be applied to develop new techniques and tools for genetic engineering and biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 1336975-57-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,6,9,7 and 5 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1336975-57:
(9*1)+(8*3)+(7*3)+(6*6)+(5*9)+(4*7)+(3*5)+(2*5)+(1*7)=195
195 % 10 = 5
So 1336975-57-5 is a valid CAS Registry Number.
1336975-57-5Relevant academic research and scientific papers
2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT
-
Page/Page column 229; 231, (2018/03/28)
The use of described compounds or pharmaceutically acceptable salts or compositions thereof for the treatment of a host infected with an RNA virus other than HCV, or other disorder more fully described herein.
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
-
Page/Page column 122; 123; 142; 143, (2017/02/02)
Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in com
COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS
-
Page/Page column 64, (2012/10/08)
Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
